A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Travera Inc
Bayer
AstraZeneca
Agenus Inc.
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Hoffmann-La Roche
Aveni Foundation
University of California, Irvine
ViroMissile, Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
University of Florida
Essen Biotech
MacroGenics
Avacta Life Sciences Ltd
Institut Curie
Solve Therapeutics
University of Nebraska
Adela, Inc
Perspective Therapeutics
Ocellaris Pharma, Inc.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Tanabe Pharma America, Inc.
Degron Therapeutics Co.
University Health Network, Toronto
University of Southern California
Blueprint Medicines Corporation
M.D. Anderson Cancer Center
Shasqi, Inc.
Memorial Sloan Kettering Cancer Center
Actym Therapeutics, Inc.
Hadassah Medical Organization
AVM Biotechnology Inc
City of Hope Medical Center
Institut Bergonié
Washington University School of Medicine
GONGCHU Biotechnology Co., Ltd
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Leap Therapeutics, Inc.
Incyte Corporation
Leap Therapeutics, Inc.
Numab Therapeutics AG
University of California, Irvine